11.88 USD
+0.05 (+0.42%)
11.88 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to VREX. VREX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. VREX has an average financial health and profitability rating. VREX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year VREX was profitable.
VREX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VREX reported negative net income in multiple years.
In the past 5 years VREX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -6.35%, VREX is in the better half of the industry, outperforming 65.59% of the companies in the same industry.
Looking at the Return On Equity, with a value of -14.88%, VREX is in the better half of the industry, outperforming 63.98% of the companies in the same industry.
VREX's Return On Invested Capital of 5.67% is fine compared to the rest of the industry. VREX outperforms 77.96% of its industry peers.
VREX had an Average Return On Invested Capital over the past 3 years of 4.82%. This is below the industry average of 8.84%.
The 3 year average ROIC (4.82%) for VREX is below the current ROIC(5.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| ROIC | 5.67% |
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
1.3 Margins
VREX has a Operating Margin of 7.83%. This is in the better half of the industry: VREX outperforms 75.27% of its industry peers.
VREX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 34.40%, VREX is doing worse than 73.66% of the companies in the same industry.
VREX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.83% | ||
| PM (TTM) | N/A | ||
| GM | 34.4% |
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VREX is destroying value.
VREX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VREX has more shares outstanding
The debt/assets ratio for VREX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.91 indicates that VREX is not a great score, but indicates only limited risk for bankruptcy at the moment.
VREX has a better Altman-Z score (1.91) than 60.22% of its industry peers.
VREX has a debt to FCF ratio of 19.87. This is a negative value and a sign of low solvency as VREX would need 19.87 years to pay back of all of its debts.
The Debt to FCF ratio of VREX (19.87) is better than 70.97% of its industry peers.
VREX has a Debt/Equity ratio of 0.79. This is a neutral value indicating VREX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.79, VREX is doing worse than 70.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 19.87 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.75
WACC7.52%
2.3 Liquidity
VREX has a Current Ratio of 3.43. This indicates that VREX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.43, VREX is in the better half of the industry, outperforming 60.75% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that VREX should not have too much problems paying its short term obligations.
The Quick ratio of VREX (1.83) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 60.00% over the past year.
Measured over the past years, VREX shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.78% on average per year.
The Revenue has been growing slightly by 4.14% in the past year.
Measured over the past years, VREX shows a small growth in Revenue. The Revenue has been growing by 2.73% on average per year.
EPS 1Y (TTM)60%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%94.74%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%11.28%
3.2 Future
VREX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.66% yearly.
Based on estimates for the next years, VREX will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y-0.32%
EPS Next 2Y7.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.92%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
VREX is valuated correctly with a Price/Earnings ratio of 13.50.
Based on the Price/Earnings ratio, VREX is valued cheaper than 89.25% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.84. VREX is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 13.54, which indicates a correct valuation of VREX.
Based on the Price/Forward Earnings ratio, VREX is valued cheaper than 89.25% of the companies in the same industry.
VREX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.5 | ||
| Fwd PE | 13.54 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VREX is valued cheaper than 95.70% of the companies in the same industry.
VREX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VREX is cheaper than 82.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.35 | ||
| EV/EBITDA | 7.54 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2Y7.66%
EPS Next 3YN/A
5. Dividend
5.1 Amount
VREX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
11.88
+0.05 (+0.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.22%
Inst Owner Change2.62%
Ins Owners1.65%
Ins Owner Change9.46%
Market Cap495.40M
Revenue(TTM)844.60M
Net Income(TTM)-70.30M
Analysts83.64
Price Target17.54 (47.64%)
Short Float %2.25%
Short Ratio3.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)251.48%
Min EPS beat(2)98.76%
Max EPS beat(2)404.2%
EPS beat(4)4
Avg EPS beat(4)167.83%
Min EPS beat(4)81.21%
Max EPS beat(4)404.2%
EPS beat(8)5
Avg EPS beat(8)85.78%
EPS beat(12)9
Avg EPS beat(12)64.21%
EPS beat(16)12
Avg EPS beat(16)54.96%
Revenue beat(2)2
Avg Revenue beat(2)3.46%
Min Revenue beat(2)2.35%
Max Revenue beat(2)4.57%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-3.1%
Max Revenue beat(4)4.57%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)5
Avg Revenue beat(12)-0.02%
Revenue beat(16)8
Avg Revenue beat(16)-0.05%
PT rev (1m)-3.37%
PT rev (3m)-1.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.05%
EPS NY rev (1m)7%
EPS NY rev (3m)-11.79%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.5 | ||
| Fwd PE | 13.54 | ||
| P/S | 0.59 | ||
| P/FCF | 26.35 | ||
| P/OCF | 11.88 | ||
| P/B | 1.05 | ||
| P/tB | 1.9 | ||
| EV/EBITDA | 7.54 |
EPS(TTM)0.88
EY7.41%
EPS(NY)0.88
Fwd EY7.38%
FCF(TTM)0.45
FCFY3.79%
OCF(TTM)1
OCFY8.42%
SpS20.25
BVpS11.33
TBVpS6.24
PEG (NY)N/A
PEG (5Y)0.23
Graham Number14.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| ROCE | 7.18% | ||
| ROIC | 5.67% | ||
| ROICexc | 6.83% | ||
| ROICexgc | 9.45% | ||
| OM | 7.83% | ||
| PM (TTM) | N/A | ||
| GM | 34.4% | ||
| FCFM | 2.23% |
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
ROICexc(3y)5.86%
ROICexc(5y)6.54%
ROICexgc(3y)8.71%
ROICexgc(5y)10.09%
ROCE(3y)6.1%
ROCE(5y)7.01%
ROICexgc growth 3Y-6.75%
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.38%
ROICexc growth 5YN/A
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
F-Score5
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 19.87 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 84.19% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 2.11 | ||
| Cash Conversion | 44.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 1.91 |
F-Score5
WACC7.52%
ROIC/WACC0.75
Cap/Depr(3y)77.68%
Cap/Depr(5y)67.38%
Cap/Sales(3y)2.78%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%94.74%
EPS Next Y-0.32%
EPS Next 2Y7.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%11.28%
Revenue Next Year3.92%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.28%
EBIT growth 3Y-8.72%
EBIT growth 5YN/A
EBIT Next Year55.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.84%
OCF growth 3Y35.13%
OCF growth 5Y25.87%
VAREX IMAGING CORP / VREX FAQ
What is the fundamental rating for VREX stock?
ChartMill assigns a fundamental rating of 5 / 10 to VREX.
Can you provide the valuation status for VAREX IMAGING CORP?
ChartMill assigns a valuation rating of 6 / 10 to VAREX IMAGING CORP (VREX). This can be considered as Fairly Valued.
What is the profitability of VREX stock?
VAREX IMAGING CORP (VREX) has a profitability rating of 5 / 10.
Can you provide the financial health for VREX stock?
The financial health rating of VAREX IMAGING CORP (VREX) is 4 / 10.
What is the earnings growth outlook for VAREX IMAGING CORP?
The Earnings per Share (EPS) of VAREX IMAGING CORP (VREX) is expected to decline by -0.32% in the next year.